Market Cap 3.93M
Revenue (ttm) 52.70M
Net Income (ttm) -38.58M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -73.21%
Debt to Equity Ratio -2.60
Volume 1,400
Avg Vol 14,012
Day's Range N/A - N/A
Shares Out 27.60M
Stochastic %K 8%
Beta -0.10
Analysts Strong Buy
Price Target $1.50

Company Profile

Centogene N.V., together with its subsidiaries, provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific. The company offers data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It provides CENTOGENE MOx 2.0, a single-step multiomic solution that combines DNA sequencing, biochemical testing, and RNA sequencing; CentoCloud, a cloud-based Software as a Service...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 49 381 80113 500
Fax: 49 381 80113 401
Address:
Am Strande 7, Rostock, Germany
Latest News on CNTGF
No data available.